We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. LONDON — Lumigan (AGN 192024, Allergan) once daily ...
In Allergan, Inc. v. Sandoz, Inc., the Federal Circuit affirmed the district court decision that upheld the validity of the Allergan patents relating to Lumigan® 0.01% glaucoma eye drops. This ...
The 691 Patent was previously the subject of invalidity allegations by Cobalt and Apotex in separate applications brought under the pre-amended Regulations. In each decision, the Federal Court found ...
The Food and Drug Administration has approved Amneal’s bimatoprost ophthalmic solution 0.01% (2.5 ml, 5 ml and 7.5 ml), which is the generic of Allergan’s Lumigan. Bimatoprost ophthalmic solution 0.01 ...
Please provide your email address to receive an email when new articles are posted on . The preservative-free gel was noninferior to a solution with benzalkonium chloride at all time points for 12 ...
Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that new nonclinical data on NCX 470 (0.1%) demonstrating greater intraocular pressure ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. LUMIGAN® PF eye drops contains the active ingredient bimatoprost.
SAN FRANCISCO Jan 14 (Reuters) - A Texas judge has upheld U.S. patents covering Allergan Inc's Lumigan glaucoma drug through 2027, the company said in a regulatory filing on Tuesday, helping to send ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results